*Some Market data delayed by 15 mins.

Evolus, Inc. Common Stock

Symbol: EOLS (NASDAQ)
0.00 ▼ (-100.00%) -6.150

Company Description:
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $6.15
  • Yesterday High: $6.285
  • Yesterday Low: $6.08
  • Yesterday Volume: 951.47K
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Evolus, Inc. Common Stock
  • Website: https://www.evolus.com
  • Listed Date: 2018-02-08
  • Location: NEWPORT BEACH, CA
  • Market Status: Active
  • CIK Number: 0001570562
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $397.17M
  • Round Lot: 100
  • Outstanding Shares: 64.69M
  • Asset Type: CS
RECENT FILINGS FOR EOLS
Filing Date Filing Type Format
2025-09-08 8-K View
2025-08-26 4 View
2025-08-18 4 View
2025-08-18 SCHEDULE 13G View
2025-08-14 SCHEDULE 13G/A View
2025-08-14 SCHEDULE 13G View
2025-08-05 10-Q View
2025-08-05 8-K View
2025-06-16 4 View
2025-06-16 144 View
2025-06-13 144 View
2025-06-10 4 View
2025-06-06 8-K View
2025-05-27 8-K View
2025-05-15 SCHEDULE 13G View
2025-05-15 SCHEDULE 13G/A View
2025-05-15 SCHEDULE 13G/A View
2025-05-14 4 View
2025-05-14 4 View
2025-05-14 4 View
Latest News on EOLS

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.